Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target, Science, vol.326, issue.5950, pp.285-294, 2009. ,
Broad diversity of neutralizing antibodies isolated from memory B cells in HIVinfected individuals, Nature, vol.458, issue.7238, pp.636-676, 2009. ,
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1, Science, vol.329, issue.5993, pp.856-61, 2010. ,
Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01, Science, vol.329, issue.5993, pp.811-818, 2010. ,
Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals, PLoS One, vol.5, issue.1, p.8805, 2010. ,
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding, Science, vol.333, issue.6049, pp.1633-1640, 2011. ,
Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing, Science, vol.333, issue.6049, pp.1593-602, 2011. ,
Broad neutralization coverage of HIV by multiple highly potent antibodies, Nature, vol.477, issue.7365, pp.466-70, 2011. ,
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody, Nature, vol.491, issue.7424, pp.406-418, 2012. ,
, Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies. Immunity, vol.37, issue.3, pp.412-425, 2012.
HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120, Proc Natl Acad Sci, vol.109, issue.30, pp.12111-12117, 2012. ,
Engineering, expression, purification, and characterization of stable clade A/B recombinant soluble heterotrimeric gp140 proteins, J Virol, vol.86, issue.1, pp.128-170, 2012. ,
Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates, J Exp Med, vol.207, issue.9, pp.2003-2020, 2010. ,
Biochemically defined HIV-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the CD4-binding site, J Biol Chem, vol.287, issue.8, pp.5673-86, 2012. ,
Rational Design of Vaccines to Elicit Broadly Neutralizing Antibodies to HIV-1. Cold Spring Harb Perspect Med, vol.1, p.7278, 2011. ,
Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination, Immunity, vol.33, issue.4, pp.542-554, 2010. ,
Rational antibody-based HIV-1 vaccine design: current approaches and future directions, Current Opinion in Immunology, vol.22, issue.3, pp.358-66, 2010. ,
Virus membrane fusion, FEBS Lett, vol.581, issue.11, pp.2150-2155, 2007. ,
Viral membrane fusion, Nat Struct Mol Biol, vol.15, issue.7, pp.690-698, 2008. ,
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1, J Virol, vol.67, issue.11, pp.6642-6649, 1993. ,
A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1, AIDS Res Hum Retroviruses, vol.17, issue.18, pp.1757-65, 2001. ,
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41, J Virol, vol.75, issue.22, pp.10892-905, 2001. ,
An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10, J Virol, vol.81, issue.8, pp.4033-4076, 2007. ,
Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope, J Virol, vol.78, pp.10724-10761, 2004. ,
Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41, Immunity, vol.22, issue.2, pp.163-73, 2005. ,
A Conformational Switch in Human Immunodeficiency Virus gp41 Revealed by the Structures of Overlapping Epitopes Recognized by Neutralizing Antibodies, J Virol, vol.83, issue.17, pp.8451-8462, 2009. ,
Atomic structure of the ectodomain from HIV-1 gp41, Nature, vol.387, issue.6631, pp.426-456, 1997. ,
Core structure of gp41 from the HIV envelope glycoprotein, Cell, vol.89, issue.2, pp.263-73, 1997. ,
Crystal Structure of HIV-1 gp41 Including Both Fusion Peptide and Membrane Proximal External Regions, PLoS Pathog, vol.6, issue.5, p.1000880, 2010. ,
Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques, Aids, vol.17, issue.3, pp.301-309, 2003. ,
Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies, J Virol, vol.73, issue.5, pp.4009-4027, 1999. ,
Protection of macaques against vaginal transmission of a pathogenic HIV-1/ SIV chimeric virus by passive infusion of neutralizing antibodies, Nat Med, vol.6, issue.2, pp.207-217, 2000. ,
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection, Nat Med, vol.6, issue.2, pp.200-206, 2000. ,
Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge, J Virol, vol.75, issue.16, pp.7470-80, 2001. ,
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers, PLoS Pathog, vol.5, issue.5, p.1000433, 2009. ,
Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies, Vaccine, vol.19, pp.3990-4001, 2001. ,
Trimeric membrane-anchored gp41 inhibits HIV membrane fusion, J Biol Chem, vol.280, issue.6, pp.4095-101, 2005. ,
Design, expression, and immunogenicity of a soluble HIV trimeric envelope fragment adopting a prefusion gp41 configuration, J Biol Chem, vol.280, issue.24, pp.23138-23184, 2005. ,
DOI : 10.1074/jbc.m414515200
URL : http://www.jbc.org/content/280/24/23138.full.pdf
Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy, J Virol, vol.81, issue.8, pp.4272-85, 2007. ,
DOI : 10.1128/jvi.02536-06
URL : http://jvi.asm.org/content/81/8/4272.full.pdf
Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles, Virology, vol.373, issue.1, pp.72-84, 2008. ,
Characterization of a trimeric MPER containing HIV-1 gp41 antigen, Virology, vol.390, issue.2, pp.221-228, 2009. ,
DOI : 10.1016/j.virol.2009.05.015
URL : https://doi.org/10.1016/j.virol.2009.05.015
Induction of HIV Neutralizing Antibodies against the MPER of the HIV Envelope Protein by HA/gp41 Chimeric Protein-Based DNA and VLP Vaccines, PLoS One, vol.6, issue.5, p.14813, 2011. ,
Multiple tandem copies of conserved gp41 epitopes incorporated in gag virus-like particles elicit systemic and mucosal antibodies in an optimized heterologous vector delivery regimen, Vaccine, vol.28, issue.43, pp.7070-80, 2010. ,
Induction of antibodies in rhesus macaques that recognize a fusionintermediate conformation of HIV-1 gp41, PLoS One, vol.6, issue.11, p.27824, 2011. ,
Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice. Vaccine, vol.30, pp.1911-1917, 2012. ,
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies, Science, vol.308, issue.5730, pp.1906-1914, 2005. ,
DOI : 10.1126/science.1111781
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation, Nature, vol.467, issue.7315, pp.591-596, 2010. ,
Role of HIV membrane in neutralization by two broadly neutralizing antibodies, Proc Natl Acad Sci, vol.106, issue.48, pp.20234-20243, 2009. ,
DOI : 10.1073/pnas.0908713106
URL : http://www.pnas.org/content/106/48/20234.full.pdf
Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions, Proc Natl Acad Sci, vol.107, issue.4, pp.1529-1563, 2010. ,
Relationship between antibody 2F5 neutralization of HIV-1 and hydrophobicity of its heavy chain third complementarity-determining region, J Virol, vol.84, issue.6, pp.2955-62, 2010. ,
Ablation of the complementarity-determining region H3 apex of the anti-HIV1 broadly neutralizing antibody 2F5 abrogates neutralizing capacity without affecting core epitope binding, J Virol, vol.84, issue.9, pp.4136-4183, 2010. ,
HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane, Immunity, vol.28, issue.1, pp.52-63, 2008. ,
DOI : 10.1016/j.immuni.2007.11.018
URL : https://doi.org/10.1016/j.immuni.2007.11.018
Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization, Nat Struct Mol Biol, vol.18, issue.11, pp.1235-1278, 2011. ,
DOI : 10.1038/nsmb.2154
URL : http://europepmc.org/articles/pmc3253551?pdf=render
Structure-guided Alterations of the gp41-directed HIV-1 Broadly Neutralizing Antibody 2F5 Reveal New Properties Regarding its Neutralizing Function, PLoS Pathog, vol.8, issue.7, p.1002806, 2012. ,
DOI : 10.1371/journal.ppat.1002806
URL : https://doi.org/10.1371/journal.ppat.1002806
Neutralizing Epitopes in the Membrane-Proximal External Region of HIV-1 gp41 Are Influenced by the Transmembrane Domain and the Plasma Membrane, J Virol, vol.86, issue.6, pp.2930-2971, 2012. ,
Direct antibody access to the HIV-1 membrane-proximal external region positively correlates with neutralization sensitivity, J Virol, vol.85, issue.16, pp.8217-8243, 2011. ,
DOI : 10.1128/jvi.00756-11
URL : http://jvi.asm.org/content/85/16/8217.full.pdf
Binding of anti-membrane-proximal gp41 monoclonal antibodies to CD4-liganded andunliganded human immunodeficiency virus type 1 and simian immunodeficiency virus virions, J Virol, vol.86, issue.3, pp.1820-1851, 2012. ,
MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1, J Exp Med, vol.208, issue.3, pp.439-54, 2011. ,
DOI : 10.1084/jem.20101907
URL : http://jem.rupress.org/content/208/3/439.full.pdf
Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10, Proc Natl Acad Sci, vol.106, issue.18, pp.7385-90, 2009. ,
A fusionintermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies, Proc Natl Acad Sci, vol.105, issue.10, pp.3739-3783, 2008. ,
Structural basis for HIV-1 neutralization by a gp41 fusion intermediatedirected antibody, Nat Struct Mol Biol, vol.13, issue.8, pp.740-747, 2006. ,
DOI : 10.1038/nsmb1127
Crystal structure and size-dependent neutralization properties of HK20, a human antibody binding to the highly conserved heptad repeat 1 of gp41, PLoS Pathogens, vol.6, issue.11, p.1001195, 2010. ,
Structural basis of HIV-1 neutralization by affinity matured Fabs directed against the internal trimeric coiled-coil of gp41, PLoS Pathog, vol.6, issue.11, p.1001182, 2010. ,
In Vivo gp41 Antibodies Targeting the 2F5 Monoclonal Antibody Epitope Mediate Human Immunodeficiency Virus Type 1 Neutralization Breadth, J Virol, vol.83, issue.8, pp.3617-3625, 2009. ,
Cross-reactive HIV1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies, J Virol, vol.85, issue.21, pp.11401-11409, 2011. ,
DOI : 10.1128/jvi.02726-13
URL : https://jvi.asm.org/content/87/24/13936.full.pdf
Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation, J Virol, vol.85, issue.22, pp.11725-11756, 2011. ,
Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting, PLoS One, vol.6, issue.9, p.23532, 2011. ,
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection, J Virol, vol.82, issue.1, pp.115-140, 2008. ,
Antigp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity, J Virol, vol.84, issue.10, pp.5032-5074, 2010. ,
DOI : 10.1128/jvi.00154-10
URL : http://europepmc.org/articles/pmc2863839?pdf=render
Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated, J Exp Med, vol.208, issue.11, pp.2237-2286, 2012. ,
DOI : 10.1084/jem.20110363
URL : http://jem.rupress.org/content/208/11/2237.full.pdf
Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance, Proc Natl Acad Sci, vol.107, issue.1, pp.181-187, 2010. ,
Naturally occurring antibodies devoid of light chains, Nature, vol.363, issue.6428, pp.446-454, 1993. ,
Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120, J Virol, vol.82, issue.24, pp.12069-12081, 2008. ,
DOI : 10.1128/jvi.01379-08
URL : https://jvi.asm.org/content/82/24/12069.full.pdf
Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1, J Biol Chem, vol.285, issue.25, pp.19116-19140, 2010. ,
CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells, Proc Natl Acad Sci, vol.107, issue.47, pp.20565-70, 2011. ,
Crystal structure of the neutralizing Llama V(HH) D7 and its mode of HIV-1 gp120 interaction, PLoS One, vol.5, issue.5, p.10482, 2010. ,
Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization, J Exp Med, vol.209, issue.6, pp.1091-103, 2012. ,
Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C, PLoS One, vol.7, issue.3, p.33298, 2012. ,
A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants, Science, vol.262, issue.5138, pp.1401-1408, 1993. ,
DOI : 10.1126/science.8248779
Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics, Clin Diagn Lab Immunol, vol.5, issue.5, pp.636-680, 1998. ,
Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage, Virology, vol.332, issue.1, pp.145-56, 2005. ,
DOI : 10.1016/j.virol.2004.10.042
URL : https://doi.org/10.1016/j.virol.2004.10.042
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T20 is modulated by coreceptor specificity defined by the V3 loop of gp120, J Virol, vol.74, issue.18, pp.8358-67, 2000. ,
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy, Antimicrob Agents Chemother, vol.46, issue.6, pp.1896-905, 2002. ,
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies, J Virol, vol.79, pp.10108-10133, 2005. ,
DOI : 10.1128/jvi.79.16.10108-10125.2005
URL : http://jvi.asm.org/content/79/16/10108.full.pdf
A subtype-specific peptide-based enzyme immunoassay for detection of antibodies to the G protein of human respiratory syncytial virus is more sensitive than routine serological tests, J Clin Microbiol, vol.35, issue.7, pp.1656-60, 1997. ,
Structural aspects of antibody-antigen interaction revealed through small random peptide libraries, Mol Divers, vol.1, issue.2, pp.87-96, 1996. ,
DOI : 10.1007/bf01721323
iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM, Acta Crystallogr D Biol Crystallogr, vol.67, pp.271-81, 2011. ,
DOI : 10.1107/s0907444910048675
URL : http://journals.iucr.org/d/issues/2011/04/00/ba5160/ba5160.pdf
Scaling and assessment of data quality, Acta Crystallogr D Biol Crystallogr, vol.62, pp.72-82, 2006. ,
Phaser crystallographic software, J Appl Crystallogr, vol.40, pp.658-674, 2007. ,
Automated protein model building combined with iterative structure refinement, Nat Struct Biol, vol.6, pp.458-463, 1999. ,
Coot: model-building tools for molecular graphics, Acta Crystallogr D Biol Crystallogr, vol.60, pp.2126-2132, 2004. ,
DOI : 10.1107/s0907444904019158
URL : http://journals.iucr.org/d/issues/2004/12/01/ba5070/ba5070.pdf
Refinement of macromolecular structures by the maximum-likelihood method, Acta Crystallogr D Biol Crystallogr, vol.53, pp.240-255, 1997. ,
Recovering lost magnetization: polarization enhancement in biomolecular NMR, J Biomol NMR, vol.49, issue.1, pp.9-15, 2010. ,
DOI : 10.1007/s10858-010-9461-5
NMRPipe: a multidimensional spectral processing system based on UNIX pipes, J Biomol NMR, vol.6, issue.3, pp.277-93, 1995. ,
DOI : 10.1007/bf00197809
The CCPN data model for NMR spectroscopy: development of a software pipeline, Proteins, vol.59, issue.4, pp.687-96, 2005. ,
Recommendations for the presentation of NMR structures of proteins and nucleic acids. IUPAC-IUBMB-IUPAB Inter-Union Task Group on the Standardization of Data Bases of Protein and Nucleic Acid Structures Determined by NMR Spectroscopy, J Biomol NMR, vol.12, issue.1, pp.1-23, 1998. ,
The HADDOCK web server for data-driven biomolecular docking, Nat Protoc, vol.5, issue.5, pp.883-97, 2010. ,
Crystallography & NMR system: A new software suite for macromolecular structure determination, Acta Crystallogr D Biol Crystallogr, vol.54, pp.905-926, 1998. ,
SAMPLEX: automatic mapping of perturbed and unperturbed regions of proteins and complexes, BMC Bioinformatics, vol.11, p.51, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00663535
TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts, J Biomol NMR, vol.44, issue.4, pp.213-236, 2009. ,
DOI : 10.1007/s10858-009-9333-z
URL : http://europepmc.org/articles/pmc2726990?pdf=render
Identification of proteinprotein interaction sites from docking energy landscapes, J Mol Biol, vol.335, issue.3, pp.843-65, 2004. ,
The HIV lipidome: a raft with an unusual composition, Proc Natl Acad Sci, vol.103, issue.8, pp.2641-2647, 2006. ,
DOI : 10.1073/pnas.0511136103
URL : http://www.pnas.org/content/103/8/2641.full.pdf
Helical peptide arrays for lead identification and interaction site mapping, Anal Biochem, vol.417, issue.1, pp.149-55, 2011. ,
DOI : 10.1016/j.ab.2011.06.002
Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: implications for fusion-inducing conformational changes, J Virol, vol.78, issue.5, pp.2627-2658, 2004. ,
Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion, Biochemistry, vol.46, issue.5, pp.1398-401, 2007. ,
Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected, J Virol, vol.85, issue.12, pp.5825-5864, 2011. ,
DOI : 10.1128/jvi.00154-11
URL : http://jvi.asm.org/content/85/12/5825.full.pdf
The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus, Nat Rev Microbiol, vol.6, issue.2, pp.143-55, 2008. ,
Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies, Nat Struct Mol Biol, vol.17, issue.12, pp.1486-91, 2010. ,
DOI : 10.1038/nsmb.1950
URL : http://europepmc.org/articles/pmc2997185?pdf=render
Enhanced HIV-1 neutralization by antibody heteroligation, Proc Natl Acad Sci, vol.109, issue.3, pp.875-80, 2012. ,
DOI : 10.1073/pnas.1120059109
URL : http://www.pnas.org/content/109/3/875.full.pdf
The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes, J Immunol, vol.178, issue.7, pp.4424-4459, 2007. ,
Membrane association and epitope recognition by HIV-1 neutralizing antigp41 2F5 and 4E10 antibodies, AIDS Res Hum Retroviruses, vol.22, issue.10, pp.998-1006, 2006. ,
Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface, Proc Natl Acad Sci, vol.106, issue.22, pp.9057-62, 2009. ,
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01, Science, vol.329, issue.5993, pp.811-818, 2010. ,
DOI : 10.1126/science.1192819
URL : http://europepmc.org/articles/pmc2981354?pdf=render
Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membraneproximal external region, Nat Struct Mol Biol, vol.17, issue.12, pp.1492-1496, 2010. ,
Rapid and quantitative cyclization of multiple peptide loops onto synthetic scaffolds for structural mimicry of protein surfaces, Chembiochem, vol.6, issue.5, pp.821-825, 2005. ,
Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines, J Virol, vol.79, issue.16, pp.10103-10110, 2005. ,